RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines. [electronic resource]
Producer: 20100311Description: 1292-301 p. digitalISSN:- 1097-4644
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis
- Carcinoma, Hepatocellular -- metabolism
- Dactinomycin -- pharmacology
- Humans
- Immunohistochemistry
- Insulin Receptor Substrate Proteins -- antagonists & inhibitors
- Liver Neoplasms -- metabolism
- RNA Interference
- Tumor Necrosis Factor-alpha -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.